News

All Press Release In The News

Aug 11,2026 Press Release

K2 Therapeutics Appoints Dr. Ying Huang as Chief Executive Officer and Announces $50 Million Seed Financing
Aug 11,2026 Endpoint News

Ying Huang’s post-Legend life takes shape at K2, with $250M goal to license Asia assets
Apr 29,2026 Endpoints News

MPM has collected three China drugs so far for its ‘best of both worlds’ strategy